New therapy calms inflammation in 'butterfly' skin

November 10, 2015, The Lead

Children with the rare genetic disease epidermolysis bullosa face a lifetime of pain due to constant blistering of their skin and other body surfaces.

The University of South Australia's Zlatko Kopecki has developed a product to help these kids, and which could potentially treat all people with inflammatory conditions.

"We have identified a harmful protein that impairs skin healing in these so-called 'butterfly children', and created a new product to address this," explained Dr Kopecki.

"More broadly, the therapy we have developed may improve recovery from all kinds of wounds."

Epidermolysis bullosa occurs due to failure in scaffold-like structures that link skin cells to each other. With the normal protective barrier to the outside world now leaky, the child's immune system is forced onto on a never-ending circuit of high alert and repair.

"If the children manage to survive the numerous infections they endure in early childhood, they die from skin cancers induced by this constant cycle," said Dr Kopecki.

The new therapy dampens harmful inflammation in the skin by blocking the activity of a protein known as Flightless.

"When extracellular Flightless protein is mopped up by specific neutralising antibodies we have developed, it results in improved healing of blistered skin and improved cellar migration," Dr Kopecki said.

The effectiveness of the antibody in reducing skin inflammation in mice is described in a recent paper published by Dr Kopecki with colleagues at the Women's and Childrens' Health Research Institute, University of South Australia and University of Adelaide.

The researchers are now focused on transitioning this finding to create a therapy that works in humans.

"We hope to run our first clinical trials in 2016 and aim to develop a marketable product within 5 years," said Dr Kopecki.

The therapy would be a welcome relief for the 500,000 people worldwide who suffer from epidermolysis bullosa.

It may also open up new opportunities to treat impaired skin healing due to diabetes, aging, burns and skin blistering, which together cost the Australian federal government in excess of AU$2.6 billion per year.

Explore further: Bacteria could contribute to development of wound-induced skin cancer

More information: Zlatko Kopecki et al. Topically Applied Flightless I Neutralizing Antibodies Improve Healing of Blistered Skin in a Murine Model of Epidermolysis Bullosa Acquisita, Journal of Investigative Dermatology (2012). DOI: 10.1038/jid.2012.457

Related Stories

Bacteria could contribute to development of wound-induced skin cancer

January 9, 2015
Researchers at King's College London have identified a new mechanism by which skin damage triggers the formation of tumors, which could have important therapeutic implications for patients suffering with chronic ulcers or ...

Collagen's role in skin cancer

October 23, 2015
Type VII collagen is an important protein that helps hold the skin together. Patients with a severe skin condition known as recessive dystrophic epidermolysis bullosa (RDEB) have genetic mutations that lead to reductions ...

More than skin deep: Researchers discover new way to help skin heal faster

November 4, 2015
Most products on the market today that are used to treat skin problems target the effects of the disease or wound such as inflammation, which can prolong the healing process and result in scarring. However, LSU Assistant ...

Stem cell therapy for inherited skin blistering

May 26, 2015
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was ...

Scientists 'switch off' defective genes in cure for skin blistering diseases

November 7, 2011
(Medical Xpress) -- Scientists have taken major steps forward to curing severe skin blistering diseases like epidermolysis bullosa which ruin thousands of lives in the UK every year.

Why patients with epidermolysis bullosa suffer extreme pain

July 8, 2011
For patients suffering from epidermolysis bullosa (EB), a hereditary skin disease, even a gentle touch is extremely painful. Now Dr. Li-Yang Chiang, Dr. Kate Poole and Professor Gary R. Lewin of the Max Delbruck Center for ...

Recommended for you

Analysis of 32 studies shows preschool, daycare do not raise asthma risk

April 10, 2018
A study that involved combing through more than 50 years of data to assess the link between asthma and daycare and preschool attendance may provide welcome reassurance to working parents. Early child care does not boost children's ...

New drug therapy could lead to more effective treatment for millions with asthma

February 7, 2018
Rutgers New Jersey Medical School researchers identified a new treatment that could lead to more effective drug therapy for millions of individuals with asthma and other respiratory disorders such as chronic obstruction pulmonary ...

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.